BioMed X and Boehringer Ingelheim start new joint research group
28-Nov-2017 -
BioMed X announced today the start of a new joint research group with Boehringer Ingelheim at the BioMed X Innovation Center in Heidelberg. The focus of the group will be to identify novel regulatory pathways within the innate immune system, through understanding molecular mechanisms employed by ...
autoimmune diseases
bacteria
Boehringer Ingelheim
+3